Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06245109 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis

Study acronym: PREDICT
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 59 wordsv7
  2. Re-verified, no change to tracked fieldsv6
  3. Primary and study completion dates: Jul 31, 2028 to Mar 15, 2028
    • Start date: Jan 31, 2024 to Feb 26, 2024
    v5
  4. Primary and study completion dates: Aug 2028 to Jul 31, 2028v4
  5. Primary endpoint revised
    • Eligibility criteria expanded, about 116 words
    v3
  6. Primary endpoint revisedv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a clinical trial of people who have pain due to knee osteoarthritis at Northwestern University Feinberg School of Medicine. The study will last for about 20 weeks. 180 qualified participants will be randomly assigned in a 1:1:1 ratio (60 participants per group) to one of three treatment groups: duloxetine, celecoxib, or placebo. Participants will have a knee Xray, (optional) MRIs of the brain and knee, blood draws, pain sensitivity testing, and asked to fill out questionnaires. The purpose of this study is to try to predict which participants will respond to the treatment.
Trial Details
NCT Number NCT06245109
Lead Sponsor Northwestern University
Collaborators: Brigham and Women's Hospital
Conditions
(from sponsor)		 Knee Osteoarthritis
Related terms Osteoarthritis, Osteoarthritis, Knee
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov